An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
Authors:
- Ciara MurphyCMCiara Murphy
- Glòria Gornés PonsGPGlòria Gornés Pons
- Anna KeoghAKAnna Keogh
- Lisa RyanLRLisa Ryan
- Lorraine McCarraLMLorraine McCarra
- Chris Maria JoseCJChris Maria Jose
- Shagun KesarShagun Kesar
- Siobhan NicholsonSNSiobhan Nicholson
- Gerard J. FitzmauriceGFGerard J. Fitzmaurice
- Ronan RyanRRRonan Ryan
- Vincent YoungVYVincent Young
- Sinead CuffeSCSinead Cuffe
Open Access
- 19 September 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (9) , 2576
Abstract
The JADE family comprises three members encoded by individual genes and roles for these proteins have been identified in chromatin remodeling, cell cycle progression, cell regeneration and the DNA damage response. JADE family members, and in particular JADE2 have not been studied in any great detail in cancer. Using a series of standard biological and bioinformatics approaches we investigated JADE2 expression in surgically resected non-small cell lung cancer (NSCLC) for both mRNA and protein to examine for correlations between JADE2 expression and overall survival. Additional correlations were identified using bioinformatic analyses on multiple online datasets. Our analysis demonstrates that JADE2 expression is significantly altered in NSCLC. High expression of JADE2 is associated with a better 5-year overall survival. Links between JADE2 mRNA expression and a number of mutated genes were identified, and associations between JADE2 expression and tumor mutational burden and immune cell infiltration were explored. Potential new drugs that can target JADE2 were identified. The results of this biomarker-driven study suggest that JADE2 may have potential clinical utility in the diagnosis, prognosis and stratification of patients into various therapeutically targetable options.Keywords
Funding Information
- Pathological Society Trainee’s Small
This publication has 76 references indexed in Scilit:
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like SignaturePLOS ONE, 2013
- Expression and Clinical Significance of Von Hippel-Lindau Downstream Genes: Jade-1 and β-Catenin Related to Renal Cell CarcinomaUrology, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Detection of Mycoplasma in cell culturesNature Protocols, 2010
- The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆European Journal of Cardio-Thoracic Surgery, 2009
- HBO1 HAT Complexes Target Chromatin throughout Gene Coding Regions via Multiple PHD Finger Interactions with Histone H3 TailMolecular Cell, 2009
- Role of Jade-1 in the Histone Acetyltransferase (HAT) HBO1 ComplexJournal of Biological Chemistry, 2008
- ING Tumor Suppressor Proteins Are Critical Regulators of Chromatin Acetylation Required for Genome Expression and PerpetuationMolecular Cell, 2006
- Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral OncoproteinsCancer Research, 2004
- The von Hippel-Lindau Tumor Suppressor Stabilizes Novel Plant Homeodomain Protein Jade-1Journal of Biological Chemistry, 2002